Induction of long-term remission in advanced hepatocellular carcinoma with percutaneous isolated liver chemoperfusion

Annals of Surgery

Volumn 227, Issue 4, 1998, Pages 519-526

  Ku, Yonson ^a   Iwasaki, Takeshi ^a   Fukumoto, Takumi ^a   Tominaga, Masahiro ^a   Muramatsu, Sanshiro ^a   Kusunoki, Nobuya ^a   Sugimoto, Takemi ^a   Suzuki, Yasuyuki ^a   Kuroda, Yoshikazu ^a   Saitoh, Yoichi ^a   Sako, Masao ^a   Matsumoto, Shinichi ^a   Hirota, Shodo ^a   Obara, Hidefumi ^a  

^a KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN;

ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; DRUG MEGADOSE; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER RESECTION; MALE; NEUTROPENIA; PRIORITY JOURNAL;

ADULT; ANTIBIOTICS, ANTINEOPLASTIC; BALLOON DILATATION; CARCINOMA, HEPATOCELLULAR; CHARCOAL; DOXORUBICIN; FEMALE; HEMOPERFUSION; HEPATIC ARTERY; HUMANS; INFUSIONS, INTRA-ARTERIAL; LIVER NEOPLASMS; MALE; MIDDLE AGED; PALLIATIVE CARE; REMISSION INDUCTION; SURVIVAL ANALYSIS;

EID: 0031879824     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000658-199804000-00012     Document Type: Article

References (21)

1. Colombo M. Hepatocellular carcinoma. J Hepatol 1992;15:225-236.
2. Tsukuma H, Hiyama T, Tanaka S, et al. Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med 1993;328:1797-1801.
3. The Liver Cancer Study Group of Japan. Primary liver cancer in Japan: Sixth report. Cancer 1987;60:1400-1411.
4. Yamada R, Sato M, Kawabata M, et al. Hepatic artery embolism in 120 patients with unresectable hepatoma. Radiology 1983;148:397-401.
5. Livraghi T, Bolondi L, Lazzaroni S, et al. Percutaneous ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis. Cancer 1992;69:925-929.
6. Doci R, Bignami P, Bozzetti F, et al. Intrahepatic chemotherapy for unresectable hepatocellular carcinoma. Cancer 1988;61:1983-1987.
7. O'connell MJ, Hahn RG, Rubin J, et al. Chemotherapy of malignant hepatomas with sequential intraarterial doxorubicin and systemic 5-fluorouracil and semustine. Cancer 1988;62:1041-1043.
8. Atiq OT, Kemeny N, Niedzwiecki D, Botet J. Treatment of unresectable primary liver cancer with intrahepatic fluorodeoxyuridine and mitomycin C through an implanted pump. Cancer 1992;69:920-924.
9. Ku Y, Saitoh M, Nishiyama H, et al. Extracorporeal removal of anticancer drugs in hepatic artery infusion: the effect of direct hemoperfusion combined with venovenous bypass. Surgery 1990;107: 273-281.
10. Ku Y, Fukumoto T, Iwasaki T, et al. Clinical pilot study on high-dose intraarterial chemotherapy with direct hemoperfusion under hepatic venous isolation in patients with advanced hepatocellular carcinoma. Surgery 1995;117:510-519.
11. Ku Y, Tominaga M, Iwasaki T, et al. Percutaneous hepatic venous isolation and extracorporeal charcoal hemoperfusion for high-dose intraarterial chemotherapy in patients with colorectal hepatic metastases. Surg Today Jpn J Surg 1996;26:305-313.
12. UICC International Union Against Liver Cancer (ICD-0155). In Hermanek P, Sobin LH, eds. TNM classification of malignant tumors. 4th ed. Berlin, Heidelberg, New York, Springer;1982:53-55.
13. Ku Y, Fukumoto T, Maeda I, et al. Single catheter technique of hepatic-venous isolation and extracorporeal charcoal hemoperfusion for malignant liver tumors. Am J Surg 1997;173:103-109.
14. 2 tests. In Armitage P, Berry G. Statistical methods in medical research. 2nd ed. Oxford, England, Blackwell Scientific; 1987:408-420.
15. Kaplan EL, Meier P. Nonparametric estimation from incomplete observation. J Am Stat Assoc 1958;53:457-481.
16. 2)/E in the log-rank test for survival data on tumor incidence data. Biometrics 1973;29:579-584.
17. Falkson G, MacIntyre IM, Moertel CG, et al. Primary liver cancer, an Eastern Cooperative Oncology Group trial. Cancer 1984;54: 970-977.
18. Marcos-Alvarez A, Jenkins RL, Washburn WK, et al. Multimodality treatment of hepatocellular carcinoma in a hepatobiliary specialty center. Arch Surg 1996;131:292-298.
19. Dexter DL, Leith JT. Tumor heterogeneity and drug resistance. J Clin Oncol 1986;4:244-257.
20. Huang C, Wu M, Xu G, et al. Overexpression of the MDR1 gene and P-glycoprotein in human hepatocellular carcinoma. J Natl Cancer Inst 1992;84:262-264.
21. Chen HSG, Gross JF. Intraarterial infusion of anticancer drugs: theoretic aspects of drug delivery and review of responses. Cancer Treat Rep 1980;64:31-40.